Jeffrey Alder - Concepedia

Author

Jeffrey Alder

Abbott Fund

Also Known As

Alder, J.D., Jeffrey Alder, Jeffrey D Alder, Jeffrey D. Alder

Publications

412

Citations

H-Index

Concepts

All Affiliations

Abbott Fund Cubist Pharmaceuticals (United States)

About

Jeffrey Alder is an author at Abbott Fund specializing in medicine, pharmacology, and medicinal chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	116
2	Health Sciences	2	2	58
3	Microbiology	2	2	58
4	Natural Sciences	1	1	37
5	Biochemistry	1	1	37

Jeffrey Alder

Publications

278

Citations

H-Index

Page 1

	Year	Citations
In Vitro Bactericidal Activities of Daptomycin against <i>Staphylococcus aureus</i> and <i>Enterococcus faecalis</i> Are Not Mediated by Inhibition of Lipoteichoic Acid Biosynthesis Valerie A. Laganas, Jeffrey Alder, Jared Silverman Antimicrobial Agents and Chemotherapy	2003	88
The advance of bacterididal drugs in the treatment of infection Jeffrey Alder, Barry I. Eisenstein Current Infectious Disease Reports Anti-infective AgentsHealth SciencesAntibioticsMedicineAntibacterial Agent	2004	38
Total synthesis and antifungal evaluation of cyclic aminohexapeptides Larry L. Klein, Leping Li, Hui-Ju Chen, Bioorganic & Medicinal Chemistry Medicinal ChemistryAntifungal AgentTotal SynthesisAntimicrobial CompoundPharmacology	2000	37
Second-Generation Peptidomimetic Inhibitors of Protein Farnesyltransferase Demonstrating Improved Cellular Potency and Significant in Vivo Efficacy Stephen J. O’Connor, Kenneth J. Barr, Le Wang, Journal of Medicinal Chemistry Chemoprevention StrategyBenzyl NitrogenPyridyl BenzylVivo EfficacyPharmacotherapy	1999	37
Daptomycin tested against 915 bloodstream isolates of viridans group streptococci (eight species) and Streptococcus bovis Jennifer M Streit, Judith N. Steenbergen, Grace M. Thorne, Journal of Antimicrobial Chemotherapy	2005	37
Efficacy of A-73209, a potent orally active agent against VZV and HSV infections Jeffrey Alder, Michael J. Mitten, Dan Norbeck, Antiviral Research Antiviral CompoundNeurovirologyAntiviral Drug DevelopmentAntiviral TherapyVirology	1994	21
In Vivo Efficacy of ABT-255 against Drug-Sensitive and -Resistant <i>Mycobacterium tuberculosis</i> Strains Andy Oleksijew, Jon Meulbroek, Patty J. Ewing, Antimicrobial Agents and Chemotherapy Antibiotic AdjuvantTuberculosis PreventionVivo EfficacyPharmacotherapyAntimicrobial Chemotherapy	1998	20

Page 1